APA   Click to copy
Leth, F. V., Phanuphak, P., Ruxrungtham, K., Baraldi, E., Miller, S., Gazzard, B., … Lange, J. (2004). Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study. The Lancet.

Chicago/Turabian   Click to copy
Leth, F. V., P. Phanuphak, K. Ruxrungtham, E. Baraldi, S. Miller, B. Gazzard, P. Cahn, et al. “Comparison of First-Line Antiretroviral Therapy with Regimens Including Nevirapine, Efavirenz, or Both Drugs, plus Stavudine and Lamivudine: a Randomised Open-Label Trial, the 2NN Study.” The Lancet (2004).

MLA   Click to copy
Leth, F. V., et al. “Comparison of First-Line Antiretroviral Therapy with Regimens Including Nevirapine, Efavirenz, or Both Drugs, plus Stavudine and Lamivudine: a Randomised Open-Label Trial, the 2NN Study.” The Lancet, 2004.

@article{f2004a,
  title = {Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study},
  year = {2004},
  journal = {The Lancet},
  author = {Leth, F. V. and Phanuphak, P. and Ruxrungtham, K. and Baraldi, E. and Miller, S. and Gazzard, B. and Cahn, P. and Lalloo, U. and van der Westhuizen, IP and Malan and Johnson, Margaret A. and Santos, B. and Mulcahy, F. and Wood, R. and Levi, GC and Reboredo, G. and Squires, K. and Cassetti, I. and Petit, D. and Raffi, F. and Katlama, C. and Murphy, R. and Horban, A. and Dam, JP and Hassink, E. and Leeuwen, R. V. and Robinson, P. and Wit, F. and Lange, J.}
}